Purchase Order 75N92020P00237
Award Date 9/3/20
Potential Completion Date 8/24/25
Potential Value $250K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Shelton, CT 06484, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc. for $5,308.00 in onsite support services. The contract has a period of performance through August 1, 2015. No set-aside was used for this award. Revvity Health Sciences, Inc. is a for-profit medical imaging company that provides laboratory equipment, maintenance services, and...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Purchase Order to Revvity Health Sciences, Inc. for a GENE ASSAY SYSTEM 1000ML with a potential value of $13,959.00. The contract has a completion date of September 28, 2018. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging products and services that has received numerous prime contracts and subcontracts from...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price purchase order contract to Revvity Health Sciences, Inc. for $5,472.00. The contract is for the provision of medical imaging products and services, with a period of performance from September 15, 2017 to September 17, 2018. This contract was not set aside for any small business category. Revvity Health Sciences, Inc. is a for-profit...
- Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a $14,616.86 firm fixed-price purchase order by the National Institutes of Health's National Heart, Lung and Blood Institute to provide a Cellometer Auto 2000 instrument. This equipment will allow the recipient laboratory to continue ongoing scientific projects and clinical protocols, as requested in Solicitation 23-016802. As the prime contractor, Revvity Health Sciences will furnish the specified...
- The Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute awarded a $108,347.60 firm-fixed-price purchase order to Revvity Health Sciences, Inc., a manufacturer of medical imaging products and services, for the delivery of an ENVISION XCITE PLATE READER. This contract has a completion date of August 16, 2023 and was awarded on August 17, 2022. No set-aside designation was used for this award. Revvity Health Sciences, Inc. is a subsidiary...
- The Department of Health and Human Services' National Institutes of Health awarded a firm fixed-price purchase order worth $176,376.98 to Revvity Health Sciences, Inc. for a Cellaca MX High Throughput-High Speed Cell Counting System and accessories. The contract is to support the National Institute of Allergy and Infectious Diseases (NIAID) and has a period of performance ending on July 30, 2023. There was no set-aside used for this acquisition, which was competed under Simplified Acquisition...
- This firm fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) to Revvity Health Sciences, Inc., a for-profit manufacturer of medical imaging products and services. The $24,821.53 contract has an ultimate completion date of October 13, 2024. It does not appear to have been set aside for any specific business type. Revvity Health Sciences has a history of providing a variety of medical devices and equipment, including automated plate readers, imaging...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $22,515 purchase order to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC, to provide unspecified services. The single year contract runs from February 20, 2024 through February 19, 2025 and utilizes a firm fixed price payment structure. Performance will occur in Bethesda, Maryland. No additional details were provided regarding the original solicitation...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Revvity Health Sciences, Inc., a for-profit manufacturer of medical imaging products and services. The contract is valued at $10,652.49 and has a period of performance from April 24, 2024 to April 23, 2025. The contract does not have a set-aside designation. Revvity Health Sciences has a history of providing a variety...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $99,222.50 firm fixed-price purchase order to Revvity Health Sciences, Inc. for a pathology imaging system. This contract, which does not have a set-aside designation, was completed on July 31, 2018. Revvity Health Sciences, Inc. is a subsidiary of the larger Revvity Inc. organization, which operates a Medical Imaging division that provides...
This firm-fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health, National Heart Lung and Blood Institute to Revvity Health Sciences, Inc., a for-profit manufacturer, to establish a Myeloid Malignancies Program Clinical and Translational Correlates Facility. The $249,663.83 contract has a completion date of August 24, 2025 and does not utilize a set-aside. Revvity Health Sciences, Inc. is a subsidiary of Revvity Inc., a for-profit organization that provides medical imaging products and services to federal agencies through prime contracts and subcontracts. This award supports the National Institutes of Health's research initiatives focused on hematological malignancies.
Generated 3/22/24, 7:11 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Myeloid Malignancies Program Clinical and Translational Correlates Facility | 75N92020Q0188 | Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute | Special Notice 1/1 | 8/11/20, 12:06 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $249.7k | 9/3/20 |